Literature DB >> 15128901

Management of cancer of the head and neck--a cocktail with your PORT?

Michele I Saunders, Ana M Rojas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15128901     DOI： 10.1056/NEJMe048038

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  [Therapy options of advanced laryngeal carcinomas with regard to the quality of life of the patients].

Authors:  Elke Hayn; Martin Burian; Johannes Gobertus Meran
Journal:  Wien Med Wochenschr       Date:  2006-05

2.  For Head and Neck Cancer, It Is Still Cisplatin, But How Much, How Often, and How Tolerable? New Randomized Phase III Data For the Adjuvant Setting.

Authors:  D Neil Hayes; John Patrick Gleysteen; David Louis Schwartz
Journal:  J Clin Oncol       Date:  2022-04-21       Impact factor: 50.717

3.  Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.

Authors:  Jérôme Fayette; Yann Molin; Emilie Lavergne; Xavier Montbarbon; Séverine Racadot; Marc Poupart; Antoine Ramade; Philippe Zrounba; Philippe Ceruse; Pascal Pommier
Journal:  Drug Des Devel Ther       Date:  2015-11-26       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.